---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-052150"
form_type: "8-K"
ticker: "CAMP"
cik: "0001736730"
company_name: "Camp4 Therapeutics Corp"
filed_at: "2026-08-04T11:10:14+00:00"
generated_at: "2026-08-04T11:15:22.436305+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# CAMP4 Therapeutics closes second tranche of $100M private placement, raising $50.1M

## Summary
- Second closing gross proceeds $50.1M from 10.76M shares at $1.53 and 21.93M pre-funded warrants at $1.5299.
- Total private placement $100M; proceeds to fund CMP-002 Phase 1/2 trial for SYNGAP1-related disorder.
- Investors include Coastlands Capital, Janus Henderson, Balyasny, Vivo Capital, 5AM Ventures, Adage Capital, Trails Edge, CURE SYNGAP1.
- Pre-funded warrants exercisable at $0.0001, subject to 19.99% beneficial ownership limitation.
- Securities issued in private placement not registered under Securities Act.

## SEC filing metadata
- accession: 0001628280-26-052150
- form_type: 8-K
- ticker: CAMP
- cik: 0001736730
- company_name: Camp4 Therapeutics Corp
- filed_at: 2026-08-04T11:10:14+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 3.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1736730/000162828026052150/0001628280-26-052150-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1736730/000162828026052150/camp-20260803.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-052150
- JSON: https://secwatch.observer/filing/0001628280-26-052150.json
- Plain text: https://secwatch.observer/filing/0001628280-26-052150.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.